澳大利亚抗生素耐药性研究小组 (AGAR) 澳大利亚黄金葡萄球菌监测结果计划 (ASSOP) 血流感染年报 2022年

Geoffrey W Coombs1, Denise A Daley2, Princy Shoby3

  • 1Antimicrobial Resistance and Infectious Diseases (AMRID) Research Laboratory, Murdoch University, Murdoch, Western Australia, Australia; Department of Microbiology, PathWest Laboratory Medicine-WA, Fiona Stanley Hospital, Murdoch, Western Australia, Australia ; Australian Group on Antimicrobial Resistance, Fiona Stanley Hospital, Murdoch, Western Australia, Australia . g.coombs@murdoch.edu.au.

概括

甲素耐药黄金葡萄球菌 (MRSA) 在2022年导致15%的澳大利亚细菌病,死亡率高于敏感菌株. 社区相关的MRSA克隆是普遍存在的,并驱动抗菌素耐药性模式.